Verona Pharma plc Cash Flow Quality Index

Latest as of June 2025: 2.56x

Verona Pharma plc cash flow quality index. Verona Pharma plc (I9SA) has a Cash Flow Quality Index of 2.56x as of June 2025. Operating cash flow of €30.56 Million exceeds net income of €11.92 Million, indicating high earnings quality where cash backs reported profits. Explore Verona Pharma plc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

2.56x

Operating CF / Net Income

Operating Cash Flow

€30.56 Million

EUR

Net Income

€11.92 Million

EUR

Data as of

Jun 2025

Most recent filing

Verona Pharma plc Cash Flow Quality Index by Year (None–None)

Verona Pharma plc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Verona Pharma plc. For the full cash flow conversion analysis, see I9SA operating cash flow.

Year	Quality Index	Operating CF (EUR)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.